Testing SIPA1L2 as a modifier of CMT1A using mouse models
George C Murray, Timothy J. Hines, Abigail L. D. Tadenev, Isaac R. L. Xu, Stephan L. Zuchner, Robert W. Burgess
The paper tests SIPA1L2 as a modifier of CMT1A using mouse models and identifies some genetic interactions but finds a small overall effect on neuropathy.
Journal of Neuropathology & Experimental Neurology · Feb 20, 2024Peer-reviewedGenetics